Green-cheeked parakeet
Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Psittaciformes; Psittacidae; Pyrrhura,
Latin Name:
Pyrrhura molinae
Tested tissues: PBMC,
Data set information
| Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
|---|---|---|---|---|---|---|
| Vthunter_0052 | 2021.04 | iDrop | PBMC | Normal | 9256 | Link |
| Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
|---|---|---|
|
Influenza A virus |
PBMC-Macrophages : 94.80% ; PBMC-B cells : 30.11% ; PBMC-Dendritic cells : 30.03% ; PBMC-Erythroid Progenitors : 29.03% ; PBMC-Platelets : 27.78% ; PBMC-Macrophages : 30.45% ; PBMC-Platelets : 8.33% ; PBMC-B cells : 7.87% ; PBMC-Erythroid Progenitors : 6.45% ; PBMC-T cells : 5.48% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Natural killer cells : 1.42% ; PBMC-Macrophages : 0.74% ; |
|
Simian rotavirus A strain RRV |
PBMC-Macrophages : 90.59% ; PBMC-B cells : 68.09% ; PBMC-Erythroid Progenitors : 66.67% ; PBMC-Platelets : 61.11% ; PBMC-T cells : 59.35% ; PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; PBMC-Platelets : 66.67% ; PBMC-Macrophages : 52.48% ; PBMC-Monocytes : 43.94% ; PBMC-Natural killer cells : 35.40% ; PBMC-Hematopoietic stem cell : 34.00% ; PBMC-Platelets : 50.00% ; PBMC-Macrophages : 36.14% ; PBMC-Monocytes : 26.61% ; PBMC-Natural killer cells : 21.96% ; PBMC-Erythroid Progenitors : 20.43% ; PBMC-Macrophages : 32.92% ; PBMC-B cells : 6.07% ; PBMC-Natural killer cells : 5.30% ; PBMC-T cells : 5.16% ; PBMC-Erythroid Progenitors : 3.23% ; |
|
Mammalian orthoreovirus |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; |
|
Human betaherpesvirus 5 |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; PBMC-Platelets : 66.67% ; PBMC-Macrophages : 52.48% ; PBMC-Monocytes : 43.94% ; PBMC-Natural killer cells : 35.40% ; PBMC-Hematopoietic stem cell : 34.00% ; PBMC-Macrophages : 32.92% ; PBMC-B cells : 6.07% ; PBMC-Natural killer cells : 5.30% ; PBMC-T cells : 5.16% ; PBMC-Erythroid Progenitors : 3.23% ; PBMC-Macrophages : 2.48% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Natural killer cells : 1.42% ; PBMC-Macrophages : 0.74% ; |
|
Human parvovirus B19 |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; |
|
Echovirus E1 |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; PBMC-Platelets : 50.00% ; PBMC-Macrophages : 36.14% ; PBMC-Monocytes : 26.61% ; PBMC-Natural killer cells : 21.96% ; PBMC-Erythroid Progenitors : 20.43% ; |
|
Equid alphaherpesvirus 1 |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; PBMC-Macrophages : 86.63% ; PBMC-B cells : 63.37% ; PBMC-T cells : 60.65% ; PBMC-Natural killer cells : 46.90% ; PBMC-Erythroid Progenitors : 32.26% ; |
|
Human gammaherpesvirus 4 | |
|
Adeno-associated virus - 2 |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; PBMC-Macrophages : 86.88% ; PBMC-B cells : 78.88% ; PBMC-T cells : 68.71% ; PBMC-Erythroid Progenitors : 63.44% ; PBMC-Hematopoietic stem cell : 26.00% ; PBMC-Macrophages : 22.28% ; PBMC-B cells : 8.31% ; PBMC-T cells : 6.45% ; PBMC-Hematopoietic stem cell : 6.00% ; PBMC-Platelets : 5.56% ; |
|
Human metapneumovirus |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; |
|
Human rotavirus strain WA |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; PBMC-Platelets : 50.00% ; PBMC-Macrophages : 36.14% ; PBMC-Monocytes : 26.61% ; PBMC-Natural killer cells : 21.96% ; PBMC-Erythroid Progenitors : 20.43% ; |
|
Foot-and-mouth disease virus |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; PBMC-Platelets : 66.67% ; PBMC-Macrophages : 52.48% ; PBMC-Monocytes : 43.94% ; PBMC-Natural killer cells : 35.40% ; PBMC-Hematopoietic stem cell : 34.00% ; PBMC-Macrophages : 32.92% ; PBMC-B cells : 6.07% ; PBMC-Natural killer cells : 5.30% ; PBMC-T cells : 5.16% ; PBMC-Erythroid Progenitors : 3.23% ; |
|
Echovirus E8 |
PBMC-Macrophages : 89.85% ; PBMC-Monocytes : 55.34% ; PBMC-Natural killer cells : 54.52% ; PBMC-Hematopoietic stem cell : 54.00% ; PBMC-T cells : 52.90% ; PBMC-Platelets : 50.00% ; PBMC-Macrophages : 36.14% ; PBMC-Monocytes : 26.61% ; PBMC-Natural killer cells : 21.96% ; PBMC-Erythroid Progenitors : 20.43% ; |
|
Dengue virus |
PBMC-Macrophages : 86.88% ; PBMC-B cells : 78.88% ; PBMC-T cells : 68.71% ; PBMC-Erythroid Progenitors : 63.44% ; PBMC-Hematopoietic stem cell : 26.00% ; PBMC-Macrophages : 8.17% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-B cells : 1.12% ; PBMC-Monocytes : 0.79% ; PBMC-Natural killer cells : 0.78% ; PBMC-Macrophages : 1.24% ; |
|
Venezuelan equine encephalitis virus |
PBMC-Macrophages : 86.88% ; PBMC-B cells : 78.88% ; PBMC-T cells : 68.71% ; PBMC-Erythroid Progenitors : 63.44% ; PBMC-Hematopoietic stem cell : 26.00% ; |
|
Adeno-associated virus - 3 |
PBMC-Macrophages : 86.88% ; PBMC-B cells : 78.88% ; PBMC-T cells : 68.71% ; PBMC-Erythroid Progenitors : 63.44% ; PBMC-Hematopoietic stem cell : 26.00% ; |
|
Sindbis virus |
PBMC-Macrophages : 86.88% ; PBMC-B cells : 78.88% ; PBMC-T cells : 68.71% ; PBMC-Erythroid Progenitors : 63.44% ; PBMC-Hematopoietic stem cell : 26.00% ; |
|
Adeno-associated virus 9 |
PBMC-Macrophages : 86.88% ; PBMC-B cells : 78.88% ; PBMC-T cells : 68.71% ; PBMC-Erythroid Progenitors : 63.44% ; PBMC-Hematopoietic stem cell : 26.00% ; |
|
Classical swine fever virus |
PBMC-Macrophages : 86.88% ; PBMC-B cells : 78.88% ; PBMC-T cells : 68.71% ; PBMC-Erythroid Progenitors : 63.44% ; PBMC-Hematopoietic stem cell : 26.00% ; |
|
Adeno-associated virus - 8 |
PBMC-Macrophages : 86.88% ; PBMC-B cells : 78.88% ; PBMC-T cells : 68.71% ; PBMC-Erythroid Progenitors : 63.44% ; PBMC-Hematopoietic stem cell : 26.00% ; |
|
Chikungunya virus |
PBMC-Macrophages : 83.42% ; PBMC-Erythroid Progenitors : 53.76% ; PBMC-B cells : 49.44% ; PBMC-T cells : 44.19% ; PBMC-Natural killer cells : 29.20% ; |
|
Lassa mammarenavirus |
PBMC-Macrophages : 80.69% ; PBMC-Erythroid Progenitors : 32.26% ; PBMC-Platelets : 25.00% ; PBMC-B cells : 21.57% ; PBMC-T cells : 20.97% ; PBMC-Macrophages : 8.91% ; PBMC-T cells : 3.23% ; PBMC-Platelets : 2.78% ; PBMC-B cells : 2.25% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Macrophages : 8.17% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-B cells : 1.12% ; PBMC-Monocytes : 0.79% ; PBMC-Natural killer cells : 0.78% ; |
|
Human immunodeficiency virus 2 | |
|
Feline immunodeficiency virus |
PBMC-B cells : 77.98% ; PBMC-T cells : 71.94% ; PBMC-Macrophages : 61.14% ; PBMC-Dendritic cells : 22.45% ; PBMC-Natural killer T cells : 22.12% ; |
|
Human immunodeficiency virus 1 | |
|
Japanese encephalitis virus |
PBMC-Macrophages : 72.28% ; PBMC-Hematopoietic stem cell : 66.00% ; PBMC-Monocytes : 65.83% ; PBMC-Natural killer T cells : 60.58% ; PBMC-Dendritic cells : 57.99% ; |
|
Coxsackievirus A9 |
PBMC-Platelets : 66.67% ; PBMC-Macrophages : 52.48% ; PBMC-Monocytes : 43.94% ; PBMC-Natural killer cells : 35.40% ; PBMC-Hematopoietic stem cell : 34.00% ; PBMC-Macrophages : 32.92% ; PBMC-B cells : 6.07% ; PBMC-Natural killer cells : 5.30% ; PBMC-T cells : 5.16% ; PBMC-Erythroid Progenitors : 3.23% ; |
|
Human gammaherpesvirus 8 |
PBMC-Platelets : 66.67% ; PBMC-Macrophages : 52.48% ; PBMC-Monocytes : 43.94% ; PBMC-Natural killer cells : 35.40% ; PBMC-Hematopoietic stem cell : 34.00% ; PBMC-Macrophages : 32.92% ; PBMC-B cells : 6.07% ; PBMC-Natural killer cells : 5.30% ; PBMC-T cells : 5.16% ; PBMC-Erythroid Progenitors : 3.23% ; |
|
Hantaan orthohantavirus |
PBMC-Platelets : 66.67% ; PBMC-Macrophages : 52.48% ; PBMC-Monocytes : 43.94% ; PBMC-Natural killer cells : 35.40% ; PBMC-Hematopoietic stem cell : 34.00% ; |
|
West Nile virus |
PBMC-Platelets : 66.67% ; PBMC-Macrophages : 52.48% ; PBMC-Monocytes : 43.94% ; PBMC-Natural killer cells : 35.40% ; PBMC-Hematopoietic stem cell : 34.00% ; PBMC-Macrophages : 32.92% ; PBMC-B cells : 6.07% ; PBMC-Natural killer cells : 5.30% ; PBMC-T cells : 5.16% ; PBMC-Erythroid Progenitors : 3.23% ; |
|
Human parechovirus 1 |
PBMC-Platelets : 66.67% ; PBMC-Macrophages : 52.48% ; PBMC-Monocytes : 43.94% ; PBMC-Natural killer cells : 35.40% ; PBMC-Hematopoietic stem cell : 34.00% ; PBMC-Macrophages : 32.92% ; PBMC-B cells : 6.07% ; PBMC-Natural killer cells : 5.30% ; PBMC-T cells : 5.16% ; PBMC-Erythroid Progenitors : 3.23% ; |
|
Argentinian mammarenavirus |
PBMC-Erythroid Progenitors : 65.59% ; PBMC-Macrophages : 14.11% ; PBMC-B cells : 11.01% ; PBMC-T cells : 4.19% ; PBMC-Natural killer T cells : 2.88% ; |
|
Canine parvovirus |
PBMC-Erythroid Progenitors : 65.59% ; PBMC-Macrophages : 14.11% ; PBMC-B cells : 11.01% ; PBMC-T cells : 4.19% ; PBMC-Natural killer T cells : 2.88% ; |
|
Hepacivirus C |
PBMC-Erythroid Progenitors : 65.59% ; PBMC-Macrophages : 14.11% ; PBMC-B cells : 11.01% ; PBMC-T cells : 4.19% ; PBMC-Natural killer T cells : 2.88% ; PBMC-Macrophages : 46.29% ; PBMC-T cells : 42.58% ; PBMC-Erythroid Progenitors : 26.88% ; PBMC-B cells : 15.51% ; PBMC-Natural killer cells : 14.73% ; PBMC-Macrophages : 20.05% ; PBMC-Platelets : 5.56% ; PBMC-Erythroid Progenitors : 4.30% ; PBMC-B cells : 3.37% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Macrophages : 16.58% ; PBMC-T cells : 5.81% ; PBMC-B cells : 4.04% ; PBMC-Natural killer cells : 3.62% ; PBMC-Monocytes : 2.84% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Natural killer cells : 1.42% ; PBMC-Macrophages : 0.74% ; PBMC-B cells : 1.80% ; PBMC-Macrophages : 1.24% ; |
|
Machupo mammarenavirus |
PBMC-Erythroid Progenitors : 65.59% ; PBMC-Macrophages : 14.11% ; PBMC-B cells : 11.01% ; PBMC-T cells : 4.19% ; PBMC-Natural killer T cells : 2.88% ; |
|
Feline panleukopenia virus |
PBMC-Erythroid Progenitors : 65.59% ; PBMC-Macrophages : 14.11% ; PBMC-B cells : 11.01% ; PBMC-T cells : 4.19% ; PBMC-Natural killer T cells : 2.88% ; |
|
Guanarito mammarenavirus |
PBMC-Erythroid Progenitors : 65.59% ; PBMC-Macrophages : 14.11% ; PBMC-B cells : 11.01% ; PBMC-T cells : 4.19% ; PBMC-Natural killer T cells : 2.88% ; |
|
Mouse mammary tumor virus |
PBMC-Erythroid Progenitors : 65.59% ; PBMC-Macrophages : 14.11% ; PBMC-B cells : 11.01% ; PBMC-T cells : 4.19% ; PBMC-Natural killer T cells : 2.88% ; |
|
Bovine leukemia virus |
PBMC-Macrophages : 59.41% ; PBMC-B cells : 19.78% ; PBMC-T cells : 17.74% ; PBMC-Erythroid Progenitors : 15.05% ; PBMC-Natural killer cells : 12.27% ; |
|
Ebola virus |
PBMC-Macrophages : 42.82% ; PBMC-Erythroid Progenitors : 13.98% ; PBMC-B cells : 13.03% ; PBMC-T cells : 10.32% ; PBMC-Hematopoietic stem cell : 6.00% ; PBMC-Macrophages : 29.70% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Dendritic cells : 1.30% ; PBMC-T cells : 1.29% ; PBMC-Natural killer cells : 1.16% ; PBMC-Macrophages : 8.17% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-B cells : 1.12% ; PBMC-Monocytes : 0.79% ; PBMC-Natural killer cells : 0.78% ; |
|
Enterovirus A71 | |
|
Coxsackievirus A16 |
PBMC-Macrophages : 35.40% ; PBMC-Hematopoietic stem cell : 6.00% ; PBMC-Platelets : 5.56% ; PBMC-T cells : 5.16% ; PBMC-B cells : 4.94% ; |
|
Human mastadenovirus B | |
|
Polytropic murine leukemia virus |
PBMC-Macrophages : 33.42% ; PBMC-Erythroid Progenitors : 17.20% ; PBMC-B cells : 15.06% ; PBMC-T cells : 10.65% ; PBMC-Natural killer cells : 6.72% ; |
|
Xenotropic murine leukemia virus |
PBMC-Macrophages : 33.42% ; PBMC-Erythroid Progenitors : 17.20% ; PBMC-B cells : 15.06% ; PBMC-T cells : 10.65% ; PBMC-Natural killer cells : 6.72% ; |
|
Human alphaherpesvirus 1 | |
|
Human mastadenovirus C | |
|
Coxsackievirus B1 |
PBMC-Macrophages : 32.92% ; PBMC-B cells : 6.07% ; PBMC-Natural killer cells : 5.30% ; PBMC-T cells : 5.16% ; PBMC-Erythroid Progenitors : 3.23% ; |
|
Human papillomavirus type 16 |
PBMC-Macrophages : 32.43% ; PBMC-Platelets : 25.00% ; PBMC-Monocytes : 24.10% ; PBMC-Natural killer cells : 20.54% ; PBMC-T cells : 15.81% ; PBMC-Macrophages : 25.50% ; PBMC-Platelets : 19.44% ; PBMC-B cells : 6.29% ; PBMC-Erythroid Progenitors : 5.38% ; PBMC-Natural killer cells : 5.04% ; |
|
Vesicular stomatitis virus |
PBMC-Macrophages : 30.45% ; PBMC-Platelets : 8.33% ; PBMC-B cells : 7.87% ; PBMC-Erythroid Progenitors : 6.45% ; PBMC-T cells : 5.48% ; |
|
Marburg marburgvirus |
PBMC-Macrophages : 29.70% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Dendritic cells : 1.30% ; PBMC-T cells : 1.29% ; PBMC-Natural killer cells : 1.16% ; PBMC-Macrophages : 8.17% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-B cells : 1.12% ; PBMC-Monocytes : 0.79% ; PBMC-Natural killer cells : 0.78% ; |
|
Porcine reproductive and respiratory syndrome virus | |
|
Simian immunodeficiency virus |
PBMC-T cells : 24.84% ; PBMC-Macrophages : 3.22% ; PBMC-B cells : 2.25% ; PBMC-Natural killer T cells : 1.92% ; PBMC-Dendritic cells : 1.45% ; |
|
Human betaherpesvirus 7 |
PBMC-T cells : 24.84% ; PBMC-Macrophages : 3.22% ; PBMC-B cells : 2.25% ; PBMC-Natural killer T cells : 1.92% ; PBMC-Dendritic cells : 1.45% ; |
|
Severe acute respiratory syndrome coronavirus 2 |
PBMC-Macrophages : 20.05% ; PBMC-Platelets : 5.56% ; PBMC-Erythroid Progenitors : 4.30% ; PBMC-B cells : 3.37% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Macrophages : 12.62% ; PBMC-Erythroid Progenitors : 10.75% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Dendritic cells : 0.97% ; PBMC-T cells : 0.97% ; |
|
Varicella Zoster Virus |
PBMC-Macrophages : 19.55% ; PBMC-B cells : 14.61% ; PBMC-T cells : 11.94% ; PBMC-Erythroid Progenitors : 9.68% ; PBMC-Natural killer T cells : 4.81% ; |
|
Human alphaherpesvirus 3 |
PBMC-Macrophages : 19.55% ; PBMC-B cells : 14.61% ; PBMC-T cells : 11.94% ; PBMC-Erythroid Progenitors : 9.68% ; PBMC-Natural killer T cells : 4.81% ; |
|
Simian sarcoma-associated virus |
PBMC-T cells : 18.06% ; PBMC-Macrophages : 11.88% ; PBMC-Erythroid Progenitors : 7.53% ; PBMC-B cells : 5.62% ; PBMC-Natural killer cells : 1.81% ; |
|
Gibbon ape leukemia virus |
PBMC-T cells : 18.06% ; PBMC-Macrophages : 11.88% ; PBMC-Erythroid Progenitors : 7.53% ; PBMC-B cells : 5.62% ; PBMC-Natural killer cells : 1.81% ; PBMC-B cells : 14.83% ; PBMC-Macrophages : 13.37% ; PBMC-Erythroid Progenitors : 5.38% ; PBMC-T cells : 4.52% ; PBMC-Hematopoietic stem cell : 4.00% ; |
|
Feline leukemia virus strain B/lambda-B1 |
PBMC-T cells : 18.06% ; PBMC-Macrophages : 11.88% ; PBMC-Erythroid Progenitors : 7.53% ; PBMC-B cells : 5.62% ; PBMC-Natural killer cells : 1.81% ; PBMC-B cells : 14.83% ; PBMC-Macrophages : 13.37% ; PBMC-Erythroid Progenitors : 5.38% ; PBMC-T cells : 4.52% ; PBMC-Hematopoietic stem cell : 4.00% ; |
|
Amphotropic murine leukemia virus |
PBMC-B cells : 14.83% ; PBMC-Macrophages : 13.37% ; PBMC-Erythroid Progenitors : 5.38% ; PBMC-T cells : 4.52% ; PBMC-Hematopoietic stem cell : 4.00% ; |
|
Feline leukemia virus strain C/FA27 |
PBMC-Macrophages : 11.63% ; PBMC-B cells : 3.37% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-Natural killer cells : 1.81% ; PBMC-T cells : 0.97% ; |
|
Coxsackievirus A10 |
PBMC-Macrophages : 11.39% ; PBMC-B cells : 2.92% ; PBMC-T cells : 2.58% ; PBMC-Natural killer T cells : 1.92% ; PBMC-Erythroid Progenitors : 1.08% ; |
|
Lymphocytic choriomeningitis mammarenavirus | |
|
Oliveros mammarenavirus |
PBMC-Macrophages : 8.91% ; PBMC-T cells : 3.23% ; PBMC-Platelets : 2.78% ; PBMC-B cells : 2.25% ; PBMC-Hematopoietic stem cell : 2.00% ; |
|
Latino mammarenavirus |
PBMC-Macrophages : 8.91% ; PBMC-T cells : 3.23% ; PBMC-Platelets : 2.78% ; PBMC-B cells : 2.25% ; PBMC-Hematopoietic stem cell : 2.00% ; |
|
Zika virus |
PBMC-Macrophages : 8.17% ; PBMC-Hematopoietic stem cell : 2.00% ; PBMC-B cells : 1.12% ; PBMC-Monocytes : 0.79% ; PBMC-Natural killer cells : 0.78% ; |
|
Nipah henipavirus |
PBMC-Macrophages : 6.93% ; PBMC-T cells : 2.26% ; |
|
Hendra henipavirus |
PBMC-Macrophages : 6.93% ; PBMC-T cells : 2.26% ; |
|
Respiratory syncytial virus |
PBMC-Macrophages : 6.68% ; PBMC-T cells : 5.81% ; PBMC-Erythroid Progenitors : 2.15% ; PBMC-Natural killer T cells : 0.96% ; |
|
Rabies lyssavirus |
PBMC-Macrophages : 6.44% ; PBMC-B cells : 5.17% ; PBMC-T cells : 1.29% ; PBMC-Erythroid Progenitors : 1.08% ; PBMC-Natural killer cells : 0.78% ; |
|
Middle East respiratory syndrome-related coronavirus |
PBMC-Macrophages : 6.19% ; PBMC-B cells : 3.60% ; PBMC-T cells : 3.55% ; PBMC-Hematopoietic stem cell : 2.00% ; |
|
JC polyomavirus |
PBMC-Erythroid Progenitors : 5.38% ; PBMC-Macrophages : 4.95% ; PBMC-Natural killer cells : 4.65% ; PBMC-Monocytes : 3.90% ; PBMC-Natural killer T cells : 2.88% ; |
|
Human coronavirus 229E |
PBMC-Macrophages : 2.48% ; |
|
Feline coronavirus |
PBMC-Macrophages : 2.48% ; |
|
Infectious bronchitis virus |
PBMC-Macrophages : 2.48% ; |
|
Canine coronavirus |
PBMC-Macrophages : 2.48% ; |
|
Transmissible gastroenteritis virus |
PBMC-Macrophages : 2.48% ; |
|
Porcine epidemic diarrhea virus |
PBMC-Macrophages : 2.48% ; |
|
Encephalomyocarditis virus |
PBMC-B cells : 1.80% ; PBMC-T cells : 1.61% ; |
|
Hepatitis E virus |
PBMC-B cells : 1.57% ; |
|
Canine morbillivirus |
PBMC-B cells : 1.57% ; PBMC-Macrophages : 0.99% ; |
|
Rinderpest morbillivirus |
PBMC-B cells : 1.57% ; PBMC-Macrophages : 0.99% ; |
|
Phocine morbillivirus |
PBMC-B cells : 1.57% ; PBMC-Macrophages : 0.99% ; |
|
Measles morbillivirus |
PBMC-B cells : 1.57% ; PBMC-Macrophages : 0.99% ; |
|
Human alphaherpesvirus 2 |
PBMC-Macrophages : 1.24% ; |
|
Suid alphaherpesvirus 1 |
PBMC-Macrophages : 1.24% ; |
|
Bovine alphaherpesvirus 1 |
PBMC-Macrophages : 1.24% ; |
|
Ecotropic murine leukemia virus |
PBMC-Erythroid Progenitors : 1.08% ; PBMC-Macrophages : 0.99% ; |
|
Jaagsiekte sheep retrovirus |
PBMC-Macrophages : 0.99% ; |
|
Human mastadenovirus F |
PBMC-Macrophages : 0.74% ; |
|
Coxsackievirus B3 |
PBMC-Macrophages : 0.74% ; |
|
Coxsackievirus B6 |
PBMC-Macrophages : 0.74% ; |
|
Human mastadenovirus E |
PBMC-Macrophages : 0.74% ; |
|
Human mastadenovirus A |
PBMC-Macrophages : 0.74% ; |